MicroRNA: Friend or foe? | PDF (287 KB)

p497 | doi:10.1038/nrc1658

Immunotherapy: Don't peak too soon... | PDF (213 KB)

p498 | doi:10.1038/nrc1656

Diagnostics: Auspicious antigens | PDF (160 KB)

p499 | doi:10.1038/nrc1655

Mouse models: Knocking in is the new knocking out | PDF (184 KB)

p500 | doi:10.1038/nrc1657

Angiogenesis: All tied up | PDF (413 KB)

p500 | doi:10.1038/nrc1664

Immunology: B cells lead the way in tumour progression | PDF (308 KB)

p501 | doi:10.1038/nrc1662

Structural biology: Spirals and curls | PDF (145 KB)

p502 | doi:10.1038/nrc1654

Chemoprevention: A cellular chill-out pill? | PDF (143 KB)

p503 | doi:10.1038/nrc1663

The role of focal-adhesion kinase in cancer — a new therapeutic opportunity

Gordon W. McLean, Neil O. Carragher, Egle Avizienyte, Jeff Evans, Valerie G. Brunton & Margaret C. Frame

p505 | doi:10.1038/nrc1647

• Abstract
• Full Text
• PDF (494 KB)

Repopulation of cancer cells during therapy: an important cause of treatment failure

John J. Kim & Ian F. Tannock

p516 | doi:10.1038/nrc1650

• Abstract
• Full Text
• PDF (398 KB)

The sweet and sour of cancer: glycans as novel therapeutic targets

Mark M. Fuster & Jeffrey D. Esko

p526 | doi:10.1038/nrc1649

• Abstract
• Full Text
• PDF (840 KB)

The anaemia of cancer: death by a thousand cuts

Jerry L. Spivak

p543 | doi:10.1038/nrc1648

• Abstract
• Full Text
• PDF (519 KB)